NOTE 6 – SHARE-BASED PAYMENTS TO VENDORS

In the fourth quarter of 2024, the Company entered into a 12-month agreement with a vendor pursuant to which the Company made quarterly grants of 500 shares of common stock. The equity payments were expensed consistently over the contractual vesting period. Pursuant to the agreement, the Company issued 1,500 shares of common stock with grant date fair values of $16.80, $8.20 and $8.12 and recorded general and administrative expenses of $4,059 and $16,559 for the three and nine months ended September 30, 2025, respectively, and $0 for each of the three and nine months ended September 30, 2026.

In addition, in the fourth quarter of 2024, the Company entered into a 12-month agreement with a vendor pursuant to which the Company made quarterly grants equal to $21,000 worth of common stock and certain cash payments. The cash payments were expensed over the service period and the equity components were expensed consistently over the contractual vesting period. Pursuant to the agreement, the Company issued 7,101 shares of common stock with grant date fair value of $14.60, $8.60 and $6.60 and recorded general and administrative expenses of $21,000 and $63,000 for the three and nine months ended September 30, 2025, respectively. This agreement was renewed in the fourth quarter of 2025 for an additional 12-month term and pursuant to the agreement, the Company issued 33,231 shares of common stock with a grant date fair value of $2.38, $2.16 and $1.43 and recorded general and administrative expenses of $21,000 and $62,999 for the three and nine months ended September 30, 2026, respectively.

In the first quarter of 2025, the Company entered into an agreement with a vendor to provide investor relations services for a six-month term. Pursuant to the agreement, the Company issued a total of 12,000 shares of common stock and made a certain cash payment. The cash payment and the equity components were expensed consistently over the contractual vesting period. The Company

issued 12,000 shares of common stock with grant date fair values ranging from $6.80 to $16.20, and recorded general and administrative expenses of $0 for each of the three months ended September 30, 2026 and 2025 and $0 and $124,280 for the nine months ended September 30, 2026 and 2025, respectively.

In the second quarter of 2025, the Company entered into an agreement with a vendor to provide investor relations services for a six-month term. Pursuant to the agreement, the Company issued 2,300 shares of common stock with a grant date fair value of $7.60 and recorded general and administrative expense of $0 and $17,480 for the three and nine months ended September 30, 2025. This agreement was amended in the third quarter of 2025 and in the second quarter of 2026 for additional six-month terms each. Pursuant to the amended agreements, the Company made monthly grants equal to $20,000 worth of common stock and certain cash payments. The cash payments and the equity components were expensed consistently over the contractual vesting period. Pursuant to the first amendment, the Company issued 4,861 shares of common stock with a grant date fair value of $4.11 and recorded general and administrative expenses of $20,000 for the three and nine months ended September 30, 2025, respectively. Pursuant to the second amendment, the Company issued 83,671 shares of common stock with grant date fair values ranging from $1.42 to $3.43 and recorded general and administrative expenses of $60,000 and $160,000 for the three and nine months ended September 30, 2026, respectively.